Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells

International Journal of Molecular Sciences

Volumn 12, Issue 11, 2011, Pages 7772-7784

  Šereš, Mário ^a   Cholujová, Dana ^b   Bubenčíkova, Tatiana ^a   Breier, Albert ^a   Sulová, Zdenka ^a  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^b CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

L1210; N glycosylation; P gp (MDR1); Tunicamycin

Indexed keywords

GLYCOPROTEIN P; TUNICAMYCIN; VINCRISTINE; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENETIC TRANSFECTION; LEUKEMIA L 1210; MOUSE; NONHUMAN; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; GLYCOSYLATION; METABOLISM; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; GLYCOSYLATION; MICE; P-GLYCOPROTEINS; TUNICAMYCIN; VINCRISTINE;

EID: 82255185758     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12117772     Document Type: Article

References (31)

1. Breier, A.; Barancik, M.; Sulova, Z.; Uhrik, B. P-glycoprotein-implications of metabolism of neoplastic cells and cancer therapy. Curr. Cancer Drug Targets 2005, 5, 457-468.
2. Baguley, B.C. Multidrug resistance in cancer. Methods Mol. Biol. 2010, 596, 1-14.
3. Breier, A.; Drobna, Z.; Docolomansky, P.; Barancik, M. Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study. Neoplasma 2000, 47, 100-106.
4. Greer, D.A.; Ivey, S. Distinct N-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES-SA/Dx5. Biochim. Biophys. Acta 2007, 1770, 1275-1282.
5. Loo, T.W.; Bartlett, M.C.; Clarke, D.M. Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein. Biochem. Biophys. Res. Commun. 2004, 325, 580-585.
6. Schinkel, A.H.; Kemp, S.; Dolle, M.; Rudenko, G.; Wagenaar, E. N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. J. Biol. Chem. 1993, 268, 7474-7481.
7. Loo, T.W.; Clarke, D.M. Quality control by proteases in the endoplasmic reticulum. Removal of a protease-sensitive site enhances expression of human P-glycoprotein. J. Biol. Chem. 1998, 273, 32373-32376.
8. Bretthauer, R.K. Structure, expression, and regulation of UDP-GlcNAc: dolichol phosphate GlcNAc-1-phosphate transferase (DPAGT1). Curr. Drug Targets 2009, 10, 477-482.
9. Ledoux, S.; Yang, R.; Friedlander, G.; Laouari, D. Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response. Cancer Res. 2003, 63, 7284-7290.
10. Gaddameedhi, S.; Chatterjee, S. Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic study employing molecular genomics. J. Cancer Res. Ther. 2009, 5, S61-S66.
11. Werno, C.; Zhou, J.; Brune, B. A23187, ionomycin and thapsigargin upregulate mRNA of HIF-1alpha via endoplasmic reticulum stress rather than a rise in intracellular calcium. J. Cell Physiol. 2008, 215, 708-714.
12. Hiss, D.C.; Gabriels, G.A.; Folb, P.I. Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells. Cancer Cell Int. 2007, 7, 5.
13. Zhang, Z.; Wu, J.Y.; Hait, W.N.; Yang, J.M. Regulation of the stability of P-glycoprotein by ubiquitination. Mol. Pharmacol. 2004, 66, 395-403.
14. Polekova, L.; Barancik, M.; Mrazova, T.; Pirker, R.; Wallner, J.; Sulova, Z.; Breier, A. Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein. Neoplasma 1992, 39, 73-77.
15. Sulova, Z.; Ditte, P.; Kurucova, T.; Polakova, E.; Rogozanova, K.; Gibalova, L.; Seres, M.; Skvarkova, L.; Sedlak, J.; Pastorek, J., et al. The presence of P-glycoprotein in L1210 cells directly induces down-regulation of cell surface saccharide targets of concanavalin A. Anticancer Res. 2010, 30, 3661-3668.
16. Fiala, R.; Sulova, Z.; El-Saggan, A.H.; Uhrik, B.; Liptaj, T.; Dovinova, I.; Hanusovska, E.; Drobna, Z.; Barancik, M.; Breier, A. P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents. Biochim. Biophys. Acta 2003, 1639, 213-224.
17. Sulova, Z.; Mislovicova, D.; Gibalova, L.; Vajcnerova, Z.; Polakova, E.; Uhrik, B.; Tylkova, L.; Kovarova, A.; Sedlak, J.; Breier, A. Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides. J. Proteome Res. 2009, 8, 513-520.
18. Parfett, C.L.; Jamieson, J.C.; Wright, J.A. Changes in cell surface glycoproteins on non-differentiating L6 rat myoblasts selected for resistance to concanavalin A. Exp. Cell Res. 1983, 144, 405-415.
19. Eneroth, A.; Astrom, E.; Hoogstraate, J.; Schrenk, D.; Conrad, S.; Kauffmann, H.M.; Gjellan, K. Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur. J. Pharm. Sci. 2001, 12, 205-214.
20. Karaszi, E.; Jakab, K.; Homolya, L.; Szakacs, G.; Hollo, Z.; Telek, B.; Kiss, A.; Rejto, L.; Nahajevszky, S.; Sarkadi, B., et al. Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia. Br. J. Haematol. 2001, 112, 308-314.
21. Ross, D.D. Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome. Best Pract. Res. Clin. Haematol. 2004, 17, 641-651.
22. Morin, M.J.; Porter, C.W.; McKernan, P.; Bernacki, R.J. The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells. J. Cell Physiol. 1983, 114, 162-172.
23. Seres, M.; Ditte, P.; Breier, A.; Sulova, Z. Effect of thapsigargin on P-glycoprotein-negative and P-glycoprotein-positive L1210 mouse leukaemia cells. Gen. Physiol. Biophys. 2010, 29, 396-401.
24. Kramer, R.; Weber, T.K.; Arceci, R.; Ramchurren, N.; Kastrinakis, W.V.; Steele, G., Jr.; Summerhayes, I.C. Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype. Br. J. Cancer 1995, 71, 670-675.
25. Bentley, J.; Quinn, D.M.; Pitman, R.S.; Warr, J.R.; Kellett, G.L. The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation. Cancer Lett. 1997, 115, 221-227.
26. Gervasoni, J.E., Jr.; Taub, R.N.; Rosado, M.; Krishna, S.; Stewart, V.J.; Knowles, D.M.; Bhalla, K.; Ross, D.D.; Baker, M.A.; Lutzky, J., et al. Membrane glycoprotein changes associated with anthracycline resistance in HL-60 cells. Cancer Chemother. Pharmacol. 1991, 28, 93-101.
27. Pastan, I.; Gottesman, M.M.; Ueda, K.; Lovelace, E.; Rutherford, A.V.; Willingham, M.C. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA 1988, 85, 4486-4490.
28. Gerlier, D.; Thomasset, N. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 1986, 94, 57-63.
29. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
30. Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76, 4350-4354.
31. Krishan, A.; Dandekar, P.D. DAPI fluorescence in nuclei isolated from tumors. J. Histochem. Cytochem. 2005, 53, 1033-1036.